Delisting risk
Alaunos Therapeutics (TCRT)
Preclinical developer of ALN1003, an oral small molecule for obesity.
$1.69
At close+0.03 (+1.81%)
Something off on this page? Send us feedback.
Next report
Nov 17, 2026
in 75 days
EPS estimate
−$15.75
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.46−$0.67−$0.63−$0.55−$0.40−$0.59−$0.41Pending
Estimate−$4.50−$6.44−$5.33−$4.90−$3.69——−$15.75
Surprise+89.8%+89.6%+88.2%+88.8%+89.1%———
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$4.0K$2.0K——$3.0K——Pending
Estimate————$3.0K———
Surprise————0.0%———
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$15.75 | — | — |
| Aug 2026 | — | −$0.41 | — |
| May 2026 | — | −$0.59 | — |
| Mar 2026 | −$3.69 | −$0.40 | +89.1% |
| Nov 2025 | −$4.90 | −$0.55 | +88.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Apr 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | −$15.75 | — | — | — | — | — | — |
| Aug 14, 2026 | — | −$0.41 | — | — | — | — | −3.0% |
| May 15, 2026 | — | −$0.59 | — | — | — | — | −0.4% |
| Mar 31, 2026 | −$3.69 | −$0.40 | +89.1% | $3.0K | $3.0K | 0.0% | +3.2% |
| Nov 14, 2025 | −$4.90 | −$0.55 | +88.8% | — | — | — | +8.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 15, 2024 | |||||||
| Apr 2, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 7, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Apr 29, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 8, 2019 | |||||||
| Mar 5, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 10, 2018 | |||||||
| Apr 30, 2018 | |||||||
| Nov 6, 2017 | |||||||
| Jul 31, 2017 | |||||||
| May 1, 2017 | |||||||
| Feb 16, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 10, 2016 | |||||||
| Feb 24, 2016 | |||||||
| Nov 2, 2015 | |||||||
| Aug 10, 2015 | |||||||